LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD
Market Cap: 45.8m USD

LAVA Therapeutics NV
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Research & Development
-$28.5m
CAGR 3-Years
9%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Research & Development
-$88.4m
CAGR 3-Years
8%
CAGR 5-Years
-25%
CAGR 10-Years
-21%
ProQR Therapeutics NV
NASDAQ:PRQR
Research & Development
-€45.4m
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
Uniqure NV
NASDAQ:QURE
Research & Development
-$139.7m
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
-11%
argenx SE
XBRU:ARGX
Research & Development
-$977.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Research & Development
-$328.5m
CAGR 3-Years
-37%
CAGR 5-Years
-37%
CAGR 10-Years
-35%
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Research & Development?
Research & Development
-28.5m USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Research & Development amounts to -28.5m USD.

What is LAVA Therapeutics NV's Research & Development growth rate?
Research & Development CAGR 5Y
-28%

Over the last year, the Research & Development growth was 13%. The average annual Research & Development growth rates for LAVA Therapeutics NV have been 9% over the past three years , -28% over the past five years .

Back to Top